EU drug watchdog deals another blow to Cladribine
Posted: Fri Jan 21, 2011 12:52 am
European regulators dealt Merck KGaA another blow by sticking with their recommendation against what once was the group's biggest pipeline hope, multiple sclerosis (MS) pill cladribine.
The European Union's drugs watchdog, which had already recommended against cladribine in September, prompting an appeal from Merck, still found that the benefits of cladribine tablets did not outweigh its risks, Merck said on Friday.
The regulator, whose view is invariably adopted by the European Commission for approval decisions, had in September mainly taken issue with cases of cancer........Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1629